Removal of Surgical Staples After Cesarean Delivery. Randomized Control Trial.
ROCD
Early Versus Late Removal of Surgical Staples After Cesarean Delivery. Randomized Control Trial.
1 other identifier
interventional
104
1 country
1
Brief Summary
The optimal choice of skin closure at cesarean delivery has not yet been determined. This study aim to study the wound complications and scar healing after Surgical staples removal at postoperative day 4 and day 8 . A randomized control trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 22, 2017
CompletedFirst Posted
Study publicly available on registry
February 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2017
CompletedMay 8, 2018
February 1, 2017
9 months
February 22, 2017
May 2, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Patient and Observer Scar Assessment Scale (POSAS) scores.
8 weeks postoperative
Secondary Outcomes (1)
complications of surgical site infection (SSI) or wound disruption (hematoma or seroma).
8 weeks postoperative
Study Arms (2)
POD4
OTHERREMOVAL OF SURGICAL STAPLES AT POSTOPERATIVE DAY 4
POD8
OTHERREMOVAL OF SURGICAL STAPLES AT POSTOPERATIVE DAY 8
Interventions
Removal of surgical clips at day 4 post operative vs day 8 post operative
Eligibility Criteria
You may qualify if:
- elective cesarean delivery
- previous cesarean delivery performed using the Pfannenstiel method
- weeks of gestation based on first trimester ultrasound and a viable fetus.
You may not qualify if:
- emergency cesarean delivery
- clinical signs of infection at the time of CD, uncontrolled
- vunblanaced diabetes mellitus
- history of keloids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wolfson medical center
Holon, Israel
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Hadas Miremberg, MD
Wolfson Medical Center- Tel Aviv University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2017
First Posted
February 24, 2017
Study Start
February 1, 2017
Primary Completion
October 30, 2017
Study Completion
October 30, 2017
Last Updated
May 8, 2018
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share